USPTO serial 88958777
IOVANCECARES
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEVERLY, JOSETTE MICHELLE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IOVANCECARES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carla B. Oakley
Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLPONE MARKET, SPEAR STREET TOWERSAN FRANCISCO, CA 94105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceuticals for the treatment of oncological disease and disorders, cancer and tumors; pharmaceutical preparations for use in immunotherapy for the treatment of oncological disease and disorders | ACTIVE | — |
| 009 | recorded computer software, downloadable computer software and downloadable mobile applications for data analysis for immunotherapy treatments and research; recorded computer software, downloadable computer software and downloadable mobile applications for tracking and monitoring chain of custody and chain of identity of cell therapies; recorded computer software, downloadable computer software and downloadable mobile applications for scheduling and tracking medical patient appointments, medical and healthcare services and medical laboratory services, for facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care and virtual health care services; recorded computer software, downloadable computer software and downloadable mobile applications for processing medication reimbursement and payer assistance services, patient support services, and hospital support services; recorded computer software, downloadable computer software and downloadable mobile applications for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing referrals in the medical and healthcare fields; recorded computer software, downloadable computer software and downloadable mobile applications for messaging and chat in the medical and healthcare fields; recorded computer software, downloadable computer software and downloadable mobile applications for locating doctors, physician's assistants, nurses, nutritionists, therapists, healthcare professionals and healthcare service providers; recorded computer software, downloadable computer software and downloadable mobile applications for providing medical diagnosis, consultation, treatment recommendations, and medical care services and information; recorded computer software, downloadable computer software and downloadable mobile applications for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatments | ACTIVE | — |
| 035 | medical appointment scheduling services; confirming scheduled appointments for others in the field of cancer treatments; physician referral services; hospital referral services; providing online physician and hospital directories on the internet; processing of online orders of prescriptions | ACTIVE | — |
| 036 | financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services; providing information regarding pharmaceutical cost reimbursements; providing assistance to patients regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage | ACTIVE | — |
| 038 | telecommunications services, namely, transmission of voice, audio, data, graphics, and video between patients and healthcare providers via global and local computer networks in the fields of telehealth, telemedicine, remote care, and virtual health care services; providing users with real-time and on-demand access to health care professionals via computer, telephone, and other electronic means via telecommunication networks | ACTIVE | — |
| 042 | providing temporary use of non-downloadable computer software for scheduling and tracking medical patient appointments, medical laboratory services, medical procedures, and for matching patients and medical treatment sites, and for use in providing data analytics in the fields of medical research, cancer treatments and drug and immunotherapy development; providing an interactive website featuring technology that allows users to communicate with patients and manage patient treatment data, for facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care and virtual health care services; software as a service (SaaS) services featuring software for delivering streamlined medical treatment information and improving communication among stakeholders in medical treatment and medical research; software as a service (SaaS) services featuring software for tracking and monitoring chain of custody and chain of identity of cell therapies; providing medical and scientific research information in the field of drug development and medical treatment development for delivering streamlined treatment information and improving communication among stakeholders in providing medical treatment; providing medical and scientific research information in the fields of medical research and cancer treatments; providing temporary use of non-downloadable software for providing medical referrals; software as a service (SAAS) services featuring software for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care, and virtual health care services; software as a service (SAAS) services featuring software for scheduling medical and healthcare services; software as a service (SAAS) services featuring software for providing consultation, and medical care services and information; providing temporary use of on-line non-downloadable software for remote medical consultation in the field of telemedicine; platform as a service (PAAS) featuring computer software platforms for online collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the medical and healthcare fields; software as a service (SAAS) services featuring software for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatments | ACTIVE | — |
| 044 | medical services, namely, resection of tumor and modifying cells for the treatment of cancer and other diseases and medical conditions; immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical information, consultancy and advisory services; providing a web site featuring medical information and information relating to pharmaceuticals; providing medical and health information relating to pharmaceuticals; medical, telehealth, remote care and virtual health care services, namely, providing medical services and consultation over the telephone and via the Internet through the use of personal computers, smartphones, tablets, and mobile wireless devices via video, email, or a global computer network; providing medical services, telehealth services in the nature of telemedicine services, remote health care services, and virtual health care services via a web site and mobile app featuring health and medical information; providing telemedicine and virtual health care services for the diagnosis, consultation, and treatment of oncological or immune system conditions; medical counseling; consulting services in the field of medical care; medical, immunotherapy and pharmaceutical consultation; medical analysis services for diagnostic and treatment purposes provided by medical laboratories | ACTIVE | — |
| 045 | providing patient advocate and case management services in the field of oncology and immunotherapy treatments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Iovance Biotherapeutics, Inc.
- Other trademarks owned by Iovance Biotherapeutics, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named IOVANCECARES
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 16, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 15, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 24, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 23, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 23, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 17, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 17, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 6, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 1, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 1, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 1, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 21, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 19, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 19, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 19, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 23, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 23, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 23, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 7, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 3, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 3, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 3, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 25, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 21, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 21, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 21, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 15, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 20, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 20, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 12, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 27, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 27, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 27, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 27, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 13, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 13, 2020 | NWAP | NEW APPLICATION ENTERED | — |